FDA Approves Supplemental Application for Zyrtec Hives by Kenvue Brands
The FDA has approved a supplemental application for Zyrtec Hives, containing cetirizine hydrochloride.
Therapeutic Area
Therapeutic area intelligence for Allergy with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.
No related entities indexed yet.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.